Wird geladen...
Unmet needs of chronic hepatitis C in the era of direct-acting antiviral therapy
The treatment of chronic hepatitis C (CHC) has been revolutionized in an era of all-oral direct-acting antivirals (DAAs) since 2014. Satisfactory treatment efficacy and tolerability can be provided by novel DAAs. Nevertheless, there are still some unmet needs and emerging issues in the treatment of...
Gespeichert in:
| Veröffentlicht in: | Clin Mol Hepatol |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
The Korean Association for the Study of the Liver
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7364348/ https://ncbi.nlm.nih.gov/pubmed/32188235 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3350/cmh.2020.0018 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|